106 related articles for article (PubMed ID: 7078802)
21. Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.
Zielinski C; Pehamberger H; Endler AT; Knapp W
Clin Exp Immunol; 1979 Oct; 38(1):92-8. PubMed ID: 393441
[TBL] [Abstract][Full Text] [Related]
22. Changes in the rosette forming capacity of lymphocytes after surgery or surgery and immunochemotherapy of malignant melanoma in man.
Hadjikirova M; Boeva M; Ikonopisov R
Biomed Pharmacother; 1982; 36(5):257-9. PubMed ID: 7168802
[TBL] [Abstract][Full Text] [Related]
23. [Intralymphatic treatment of lymph-node metastases with Lipiodol labeled with I-131, with special reference to malignant melanoma].
Edwards JM
Minerva Med; 1967 Dec; 58(99):4512-3. PubMed ID: 4295505
[No Abstract] [Full Text] [Related]
24. The effect of BCG on B16 mouse melanoma: a comparison of routes of administration on tumour growth at different anatomical sites.
Proctor JW; Auclair BG; Lewis MG
Eur J Cancer (1965); 1976 Mar; 12(3):203-10. PubMed ID: 939237
[No Abstract] [Full Text] [Related]
25. Controlled study for prolonged chemotherapy, immunotherapy, and chemotherapy plus immunotherapy as an adjuvant to surgery in malignant melanoma (Trial 6): preliminary report.
Veronesi U; Beretta G
Recent Results Cancer Res; 1978; 68():375-9. PubMed ID: 752873
[No Abstract] [Full Text] [Related]
26. Monocytopoiesis in malignant melanoma: untreated, during immunotherapy and chemoimmunotherapy.
Schmitt E; Meuret G; Waldermann F; Hagedorn M
Arch Dermatol Res; 1979 May; 264(3):319-26. PubMed ID: 464648
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of malignant melanoma].
Balch CM
Dtsch Med Wochenschr; 1985 Nov; 110(46):1786-91. PubMed ID: 4054006
[No Abstract] [Full Text] [Related]
28. Metastatic melanoma complicated by disseminated BCG.
Hon JK; Hamner RW; Bailey WC; Sheehy TW
South Med J; 1982 Oct; 75(10):1263-4. PubMed ID: 7123300
[No Abstract] [Full Text] [Related]
29. Enhanced antitumor effects with intralymphatic delivery using bacillus Calmette-Guerin in animal models.
Jeglum KA; Mangan C; Wheeler JE
Cancer Drug Deliv; 1985; 2(2):127-32. PubMed ID: 4052927
[TBL] [Abstract][Full Text] [Related]
30. Effect of intranodular B.C.G. in 22 melanoma patients.
Israël L; Depierre A; Edelstein R; Cros-Decam J; Maury P
Panminerva Med; 1975; 17(5-6):187-8. PubMed ID: 1161317
[No Abstract] [Full Text] [Related]
31. [Malignant melanoma of the esophagus (author's transl)].
Frank K; Bettendorf U; Reinhardt P
Leber Magen Darm; 1981 Jan; 11(1):37-43. PubMed ID: 7219012
[TBL] [Abstract][Full Text] [Related]
32. Letter: Routes other than I.V. injection to mice for BCG administration in active immunotherapy of L1210 leukemia.
Martin M; Bourut C; Halle-Pannenko O; Mathé
Biomedicine; 1975 Oct; 23(8):339-40. PubMed ID: 1231929
[No Abstract] [Full Text] [Related]
33. Immunotherapy and immune competence of patients with malignant melanoma.
Kovarík J; Ninger E; Mechl Z; Zemanová D; Lauerová L; Sopková B; Svejda J; Bacovský B; Bártová A; Bártek J
Czech Med; 1983; 6(3):172-4. PubMed ID: 6416794
[No Abstract] [Full Text] [Related]
34. Letter: Immunotherapy with intravenous B.C.G.
Crispen RG
Lancet; 1974 Jul; 2(7871):56. PubMed ID: 4134451
[No Abstract] [Full Text] [Related]
35. Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma.
Karakousis CP; Didolkar MS; Han T
Cancer Treat Rep; 1981; 65(9-10):925-6. PubMed ID: 7273032
[No Abstract] [Full Text] [Related]
36. Editorial: BCG treatment of malignant melanoma.
Can Med Assoc J; 1974 Feb; 110(3):258. PubMed ID: 4812144
[No Abstract] [Full Text] [Related]
37. Immunological aspects of melanomas [proceedings].
The TH; de Gast GC; Huiges HA; Schraffordt Koops H
Ophthalmologica; 1977; 175(1):25-7. PubMed ID: 904885
[No Abstract] [Full Text] [Related]
38. Immunotherapeutic activity of percutaneous BCG vaccine: laboratory and clinical studies.
Engibarov A; Chouchkova M; Ikonopisov R
Dev Biol Stand; 1986; 58 ( Pt A)():365-9. PubMed ID: 3596042
[No Abstract] [Full Text] [Related]
39. [Disseminated melanoma treatment].
Neidhardt-Bérard EM; Négrier S
Rev Prat; 2004 Jun; 54(11):1210-4. PubMed ID: 15496028
[TBL] [Abstract][Full Text] [Related]
40. Results of a nonrandomized trial in malignant melanoma patients (Clark's stages III--V) treated by post-surgical chemoimmunotherapy.
Serrou B; Pujol H; Domas J; Gauci L
Recent Results Cancer Res; 1978; 68():363-6. PubMed ID: 752871
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
